These data implicate DNA-PK as a pivotal nexus linking genomic instability to iron-dependent cell death, underscoring a potential paradigm shift in therapeutic strategies for T2DM microvascular complications. This evidence concerns the gene PRKDC and type 2 diabetes mellitus.